The GATRA is a program whose aim is to identify and support innovative clinical and scientific research aimed at gaining more insight into the current and new uses of Antithrombin.
By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care

2019-2020 cycle application now open


Given the exceptional situation with the COVID-19 pandemic, the deadline for submission of Letters of Intent has been postponed until June 30th


Please click here to apply

Supporting Investigational Research

A panel of international prestige jury members